Literature DB >> 7240249

Kinetics of coupled gamma-hydroxybutyrate oxidation and D-glucuronate reduction by an NADP+-dependent oxidoreductase.

E E Kaufman, T Nelson.   

Abstract

A highly purified NADP+-dependent oxidoreductase from hamster liver (1) has been found to catalyze a reaction in which the oxidation of gamma-hydroxybutyrate is coupled to the reduction of D-glucuronate. In the coupled reaction, NADP+ is required in catalytic rather than stoichiometric amounts. When the coupled reaction is carried out under limiting conditions for the oxidation of gamma-hydroxybutyrate (i.e. a very low concentration of NADP+ and an inhibitory concentration of NADPH) the rate of gamma-hydroxybutyrate oxidation is determined by the concentration of D-glucuronate and can be stimulated at least 8-fold by D-glucuronate. The kinetics of the oxidation of gamma-hydroxybutyrate have been studied in both the uncoupled and the coupled reaction. In the coupled reaction the reduction of D-glucuronate drives the oxidation of gamma-hydroxybutyrate; the Km for NADP+ is markedly lower than the Km determined in the uncoupled reaction (1.4 X 10(-6) M as compared to 2 X 10(-5) M), and the inhibition by NADPH can be completely overcome. The kinetics of the uncoupled reaction suggest that, unlike many other dehydrogenases, the oxidation of gamma-hydroxybutyrate catalyzed by this enzyme proceeds by a Rapid Equilibrium Random Bi Bi mechanism.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240249

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Potential gamma-hydroxybutyric acid (GHB) drug interactions through blood-brain barrier transport inhibition: a pharmacokinetic simulation-based evaluation.

Authors:  Indranil Bhattacharya; Kathleen M K Boje
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-08-29       Impact factor: 2.745

Review 2.  An overview of gamma-hydroxybutyrate catabolism: the role of the cytosolic NADP(+)-dependent oxidoreductase EC 1.1.1.19 and of a mitochondrial hydroxyacid-oxoacid transhydrogenase in the initial, rate-limiting step in this pathway.

Authors:  E E Kaufman; T Nelson
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

3.  Metabolism of levulinate in perfused rat livers and live rats: conversion to the drug of abuse 4-hydroxypentanoate.

Authors:  Stephanie R Harris; Guo-Fang Zhang; Sushabhan Sadhukhan; Anne M Murphy; Kristyen A Tomcik; Edwin J Vazquez; Vernon E Anderson; Gregory P Tochtrop; Henri Brunengraber
Journal:  J Biol Chem       Date:  2010-12-01       Impact factor: 5.157

Review 4.  gamma-Hydroxybutyrate/sodium oxybate: neurobiology, and impact on sleep and wakefulness.

Authors:  Daniel Pardi; Jed Black
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.